Annual antineoplastic medicine sales in Russia exceeded six billion Russian rubles in 2022. The revenue marked a continuous growth over the observed period, increasing by 4.2 billion compared to 2018.
Sales revenue of antineoplastic medications in Russia from 2018 to 2022 (in billion Russian rubles)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Foreign-to-Canadian generic drug price ratios by OECD country as of 2018
- Premium Statistic Canadian prices for top generic molecules 2018
- Premium Statistic Top 5 worldwide oncology products by revenue 2017 and 2024
- Basic Statistic Top U.S. oncology products by revenue in 2016
- Basic Statistic Expenditure on prescription pharmaceuticals in Sweden 2009-2023
- Basic Statistic Expenditure on nonprescription pharmaceuticals in Sweden 2009-2023
- Basic Statistic Expenditure on pharmaceuticals in Sweden 2009-2023
- Premium Statistic Leading pharmaceutical producers in Russia 2023, by revenue
- Premium Statistic Highest-earning producers of biologically active additives in Russia 2023
- Basic Statistic Orphan vs. non-orphan pipeline sales forecast worldwide 2023-2028
About the region
10
- Premium Statistic Market share of leading pharmacy chains in Russia 2022, by count
- Premium Statistic Pharma e-commerce revenue growth in Russia 2021-2022, by platform
- Premium Statistic Leading pharmaceutical distributors in Russia 2023, by market share
- Premium Statistic Leading pharma distributors in Russia 2023, by revenue
- Basic Statistic Commercial pharma market value in Russia monthly 2021-2023
- Premium Statistic Pharma market volume in packages in Russia monthly 2021-2022
- Premium Statistic Share of pharmacies in Russia 2022, by type
- Premium Statistic Pharmaceutical sales volume share in Russia 2022, by price category
- Premium Statistic Pharmaceutical market size in Russia 2012-2024
- Basic Statistic Average spend in pharmacies in Russia Q1 2021, by region
Selected statistics
6
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2023
- Premium Statistic Standard Unit medicine use per capita in the U.S. 2007-2011
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
Other regions
10
- Premium Statistic Immunoglobulin consumption in select countries 2017
- Premium Statistic Import value of pharmaceutical products in Poland 2011-2022
- Basic Statistic Employment at select top pharmaceutical companies in Denmark 2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Hindustan Antibiotics production value of FY 2014-2023
- Premium Statistic Revenue of the top ten pharmaceutical companies in France 2021
- Premium Statistic Main pharmacies in Mexico 2019, by size
- Premium Statistic Latin America: main pharmacies 2017, by number of stores
- Premium Statistic Pharmaceutical market revenue in Italy in 2022, by type of drug
- Premium Statistic China's share in U.S imports of select pharma products 2019
Related statistics
10
- Premium Statistic Pharma advertising spending in Russia 2020, by channel
- Premium Statistic Share of pharma offline ad spend in Russia 2019, by category
- Premium Statistic Leading pharmaceutical advertisers online in Russia 2019, by views share
- Premium Statistic Leading antiviral medicine brands in Russia Q1 2020, by sales share
- Premium Statistic Apteka.ru audience reach monthly 2022-2023
- Premium Statistic Leading pharma e-commerce platforms in Russia 2023, by revenue
- Premium Statistic Online share of pharmacy sales in Russia 2022-2024
- Premium Statistic Generic and original medication sales volume share in Russia 2020-2023
- Premium Statistic Inflation on pharmaceuticals in Russia 2008-2022
- Premium Statistic Leading conventional pharmacies in Russia 2022, by market share
Further related statistics
10
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co - expenditure on research and development 2006-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- GSK's operating profit by division 2006-2021
- John Lewis sales revenue in the United Kingdom (UK) 2009-2023
- Waitrose sales revenue in the United Kingdom (UK) 2009-2023
- MorphoSys' revenue 2006-2023
- Merck & Co total assets 2009-2023
- Merck & Co cash dividends declared 2006-2023
Further Content: You might find this interesting as well
Statistics
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co - expenditure on research and development 2006-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- GSK's operating profit by division 2006-2021
- John Lewis sales revenue in the United Kingdom (UK) 2009-2023
- Waitrose sales revenue in the United Kingdom (UK) 2009-2023
- MorphoSys' revenue 2006-2023
- Merck & Co total assets 2009-2023
- Merck & Co cash dividends declared 2006-2023
pharmvestnik.ru. (March 29, 2023). Sales revenue of antineoplastic medications in Russia from 2018 to 2022 (in billion Russian rubles) [Graph]. In Statista. Retrieved May 04, 2024, from https://www.statista.com/statistics/1236204/antineoplastic-medicine-sales-revenue-russia/
pharmvestnik.ru. "Sales revenue of antineoplastic medications in Russia from 2018 to 2022 (in billion Russian rubles)." Chart. March 29, 2023. Statista. Accessed May 04, 2024. https://www.statista.com/statistics/1236204/antineoplastic-medicine-sales-revenue-russia/
pharmvestnik.ru. (2023). Sales revenue of antineoplastic medications in Russia from 2018 to 2022 (in billion Russian rubles). Statista. Statista Inc.. Accessed: May 04, 2024. https://www.statista.com/statistics/1236204/antineoplastic-medicine-sales-revenue-russia/
pharmvestnik.ru. "Sales Revenue of Antineoplastic Medications in Russia from 2018 to 2022 (in Billion Russian Rubles)." Statista, Statista Inc., 29 Mar 2023, https://www.statista.com/statistics/1236204/antineoplastic-medicine-sales-revenue-russia/
pharmvestnik.ru, Sales revenue of antineoplastic medications in Russia from 2018 to 2022 (in billion Russian rubles) Statista, https://www.statista.com/statistics/1236204/antineoplastic-medicine-sales-revenue-russia/ (last visited May 04, 2024)
Sales revenue of antineoplastic medications in Russia from 2018 to 2022 (in billion Russian rubles) [Graph], pharmvestnik.ru, March 29, 2023. [Online]. Available: https://www.statista.com/statistics/1236204/antineoplastic-medicine-sales-revenue-russia/